Malin Corporation | MLC - Debt


Malin Corporation reported EUR100K in Debt for its fiscal semester ending in December of 2023.





Debt Change Date
Akebia Therapeutics USD 46.51M 7.82M Mar/2025
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
ALKERMES USD 71.6M 1.08M Sep/2025
Avita Medical AUD 46.05M 1.46M Dec/2025
Dianthus Therapeutics USD 1.28M 45K Sep/2025
Eurofins Scientific SE EUR 4.11B 503.4M Jun/2025
Ionis Pharmaceuticals USD 2.33B 1.1B Dec/2025
IQVIA Holdings USD 15.72B 767M Dec/2025
Lonza CHF 4.71B 915M Dec/2024
Malin Corporation EUR 100K 0 Dec/2023
Moderna USD 734M 7M Sep/2025
Organon & Co USD 8.83B 68M Sep/2025
Ovoca Bio EUR 0 0 Jun/2021
Revvity USD 3.37B 5.86M Sep/2025
Tectonic Therapeutic USD 876K 115K Dec/2024
Viatris USD 14.41B 25.6M Dec/2025
Xeris Pharmaceuticals USD 257.65M 431K Sep/2025